Recombinant Mycobacterium abscessus Triosephosphate isomerase (tpiA)

How is recombinant M. abscessus tpiA typically expressed and purified for research purposes?

For successful expression of recombinant M. abscessus tpiA, E. coli-based expression systems using vectors like pET with BL21(DE3) strains typically provide high yields. Optimal results are achieved using lower induction temperatures (16-20°C) and reduced IPTG concentrations (0.1-0.5 mM) to enhance soluble protein production. Including solubility-enhancing tags such as His, MBP, or SUMO can significantly improve yield and proper folding.

A systematic purification protocol includes:

• Cell lysis in buffer containing 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, and 10% glycerol

• Initial capture using immobilized metal affinity chromatography (IMAC) with Ni-NTA resin

• Size exclusion chromatography to separate oligomeric forms (active tpiA typically elutes as a dimer)

• Optional ion exchange chromatography for removing remaining contaminants

The purified protein exhibits optimal stability in 25 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5% glycerol at 4°C with longer-term storage at -80°C in the presence of 10% glycerol as a cryoprotectant.

What experimental approaches can be used to measure tpiA enzymatic activity?

TpiA activity can be measured through several complementary approaches:

• Spectrophotometric coupled assays:

  • Forward reaction (DHAP → G3P): Coupling with α-glycerophosphate dehydrogenase and monitoring NADH oxidation at 340 nm

  • Reverse reaction (G3P → DHAP): Coupling with glyceraldehyde-3-phosphate dehydrogenase and monitoring NADH formation

• Direct product quantification:

  • High-performance liquid chromatography (HPLC) to separate and quantify DHAP and G3P

  • Mass spectrometry for precise detection of substrate consumption and product formation

• Isothermal titration calorimetry (ITC) for thermodynamic parameters:

  • Determination of binding constants and reaction enthalpies

  • Assessment of substrate affinity and catalytic efficiency

Standard reaction conditions typically include 100 mM Tris-HCl (pH 7.5), 10 mM DHAP or G3P, and 0.1-1.0 μg purified enzyme at 25-37°C. Activity should be reported as specific activity (μmol/min/mg) with clearly defined assay conditions to facilitate cross-study comparisons.

How does M. abscessus tpiA compare structurally and functionally to tpiA from other mycobacterial species?

Comparative analysis of recombinant tpiA from M. abscessus and other mycobacterial species reveals both similarities and species-specific differences:

M. abscessus tpiA generally exhibits catalytic efficiency comparable to that of M. tuberculosis, with slightly higher thermal stability. The enzyme shows classic Michaelis-Menten kinetics for both substrates, with a preference for DHAP over G3P in the forward reaction. Structurally, while the catalytic core and active site geometry are highly conserved across mycobacterial species, slight variations in surface loops and the dimer interface may contribute to species-specific differences in stability and regulation.

What challenges are encountered when working with M. abscessus tpiA compared to model enzymes?

Working with M. abscessus tpiA presents several technical challenges:

• Expression and solubility issues:

  • Codon optimization is often necessary for heterologous expression

  • Tendency to form inclusion bodies in E. coli expression systems

  • Requirement for optimization of induction conditions to maximize soluble protein yields

• Stability considerations:

  • Susceptibility to oxidative inactivation during purification

  • Activity loss during freeze-thaw cycles

  • Potential for oligomerization states to impact function

• Assay interference:

  • Sensitivity of coupled enzymatic assays to buffer components

  • Phosphate contamination affecting kinetic measurements

  • Substrate degradation during extended assays

• Crystallization difficulties:

  • Challenges in obtaining diffraction-quality crystals

  • Microheterogeneity affecting crystallization success

  • Requirement for stabilizing additives during crystallization trials

These challenges can be addressed through careful optimization of expression conditions, inclusion of reducing agents throughout purification, development of robust activity assays with appropriate controls, and screening diverse crystallization conditions with various protein constructs.

How can conditional gene expression systems be optimized for studying essential genes like tpiA in M. abscessus?

Optimizing conditional gene expression systems for studying essential genes like tpiA in M. abscessus requires careful consideration of several factors:

• Selection of appropriate regulatory systems: The TetR/PipOFF system has been successfully adapted for M. abscessus . This system allows controlled repression of gene expression in response to tetracycline or its derivatives. For tpiA studies, the system can be optimized by:

  • Integrating the regulatory elements into the chromosome rather than using plasmid-based systems to ensure stability

  • Calibrating inducer concentrations to achieve graduated levels of repression rather than complete shutdown

  • Engineering the native tpiA promoter to incorporate tetracycline-responsive elements while maintaining physiological expression levels

• Verification of conditional essentiality: To confirm that tpiA is essential under specific conditions, a complemented conditional knockout approach can be employed:

  • Generate a merodiploid strain containing both the native tpiA and a second copy under a controllable promoter

  • Delete the native copy using homologous recombination techniques

  • Confirm dependency on the inducible copy by demonstrating growth only in permissive conditions

• Carbon source considerations: Based on studies in M. tuberculosis, the essentiality of tpiA may depend on carbon source availability . Therefore, expression systems should be tested under various carbon source conditions:

  • Single carbon sources (glycerol, glucose, acetate) versus mixed carbon sources

  • Carbon-limited versus carbon-rich conditions

  • In vitro versus intracellular growth conditions

These optimized conditional expression systems enable precise temporal control of tpiA expression, facilitating studies of the immediate consequences of enzyme depletion before secondary effects complicate interpretation.

How does carbon source availability affect tpiA essentiality in M. abscessus compared to M. tuberculosis?

Based on studies with M. tuberculosis and extrapolating to M. abscessus, carbon source availability critically determines tpiA essentiality:

• Single carbon source conditions:

  • In M. tuberculosis, tpiA is essential when the bacterium grows on single carbon sources (either glycolytic or gluconeogenic)

  • Similarly, M. abscessus tpiA is likely essential when the bacterium is cultured with single carbon sources like glucose, glycerol, or acetate

  • This essentiality stems from the absolute requirement for TPI in connecting the upper and lower segments of glycolysis or in gluconeogenesis

• Dual carbon source conditions:

  • In M. tuberculosis, tpiA becomes dispensable when both glycolytic (e.g., glucose) and gluconeogenic (e.g., acetate) carbon sources are simultaneously available

  • This phenomenon likely extends to M. abscessus, suggesting that dual carbon source media could be used to generate tpiA deletion mutants for further study

  • The mechanism involves the bacterium utilizing parallel pathways: glycolysis from glucose to triose phosphates and gluconeogenesis from acetate to triose phosphates, circumventing the need for TPI-mediated interconversion

• In vivo essentiality:

  • Despite dispensability in dual-carbon media in vitro, tpiA remains essential for M. tuberculosis in mouse infection models

  • This suggests that during infection, M. abscessus likely cannot simultaneously access sufficient quantities of both glycolytic and gluconeogenic carbon sources

  • The in vivo essentiality makes tpiA a potential drug target despite conditional dispensability in vitro

• Metabolic consequences of tpiA deletion:

  • 13C metabolite tracing in M. tuberculosis tpiA deletion mutants shows accumulation of TPI substrates and absence of alternative triosephosphate isomerases

  • Similar metabolic perturbations would be expected in M. abscessus tpiA mutants

What structural differences exist between M. abscessus tpiA and human TPI that could be exploited for drug development?

Structural analysis of M. abscessus tpiA compared to human TPI reveals several differences that could be exploited for selective drug development:

• Active site architecture:

  • While the catalytic residues are conserved, the surrounding residues differ in charge distribution and hydrogen bonding networks

  • M. abscessus tpiA exhibits a slightly more constricted active site channel, potentially allowing for the design of inhibitors that cannot bind to the more open human active site

• Dimer interface:

  • The dimer interface of M. abscessus tpiA contains several unique residues that participate in inter-subunit interactions not present in the human enzyme

  • These interface differences could be targeted by compounds that specifically disrupt the bacterial enzyme's quaternary structure

• Surface loops:

  • Several surface loops, particularly those that undergo conformational changes during catalysis, show sequence divergence

  • These loop regions present opportunities for developing allosteric inhibitors that bind at sites distant from the conserved active site

• Cysteine content and distribution:

  • M. abscessus tpiA contains differently positioned cysteine residues compared to human TPI

  • These cysteines could be targeted by thiol-reactive compounds to achieve selective inhibition

These structural differences provide rational targets for structure-based drug design approaches, particularly for developing allosteric inhibitors that bind outside the highly conserved active site. Molecular dynamics simulations have further revealed differences in protein flexibility and conformational sampling between the bacterial and human enzymes that could be exploited for selective inhibitor design.

How can site-directed mutagenesis of M. abscessus tpiA inform structure-function relationships?

Site-directed mutagenesis of M. abscessus tpiA provides valuable insights into structure-function relationships through systematic analysis of specific residues:

• Active site residue analysis:

  • Mutation of the catalytic glutamate to glutamine or aspartate can quantify the contribution of this residue to proton transfer during catalysis

  • Replacing the phosphate-binding loop residues can reveal the relative importance of specific interactions for substrate recognition

  • Conservative versus non-conservative substitutions of second-shell residues can identify those that fine-tune the electrostatic environment of the active site

• Dimer interface engineering:

  • TPI functions as a dimer, and interface mutations can establish the relationship between oligomerization and catalytic activity

  • Charge-reversal mutations at the interface can test the importance of specific salt bridges for dimer stability

  • Introduction of disulfide bonds across the interface can create variants with enhanced stability for structural studies

• Loop dynamics investigation:

  • TPI contains several mobile loops that undergo conformational changes during catalysis

  • Glycine/proline substitutions in these loops can alter flexibility and reveal the importance of loop motion for substrate binding and product release

  • Crosslinking strategies that restrict loop movement can identify rate-limiting conformational changes

• Substrate specificity determinants:

  • Creating chimeric enzymes with segments from human TPI can identify regions responsible for subtle differences in substrate preference

  • Point mutations at positions that differ between mycobacterial and human enzymes can reveal species-specific adaptations

Experimental execution requires:

• Optimized expression of mutant proteins in E. coli or mycobacterial systems

• Careful purification to ensure comparable protein quality across variants

• Comprehensive kinetic characterization using both spectrophotometric assays and isothermal titration calorimetry

• Structural verification by X-ray crystallography or cryo-EM when possible

What role does tpiA play in M. abscessus virulence and pathogenicity?

The role of tpiA in M. abscessus virulence and pathogenicity remains to be fully elucidated, but several lines of evidence suggest significant contributions:

• Metabolic adaptation during infection:

  • As a central metabolic enzyme, tpiA enables M. abscessus to utilize various carbon sources encountered during infection

  • Flexibility in carbon metabolism is crucial for adaptation to changing nutrient availability in different host microenvironments

  • The likely essentiality of tpiA in vivo, as shown for M. tuberculosis, suggests its critical role in sustaining infection

• Contribution to stress resistance:

  • Beyond its canonical role in glycolysis/gluconeogenesis, TPI in other bacteria has been shown to contribute to oxidative stress resistance

  • M. abscessus encounters significant oxidative stress within macrophages and neutrophils during infection

  • TPI inactivation by oxidation could serve as a metabolic checkpoint that helps regulate the bacterial response to host-derived stresses

• Impact on bacterial cell envelope:

  • Perturbations in central carbon metabolism can affect cell wall biosynthesis through altered precursor availability

  • The M. abscessus cell envelope is a key determinant of virulence, antibiotic resistance, and immune recognition

  • TPI activity may indirectly influence cell envelope composition and integrity through metabolic flux regulation

• Persistence and antibiotic tolerance:

  • Metabolic remodeling is associated with persistence and antibiotic tolerance in mycobacteria

  • TPI-dependent carbon flux may influence the formation of persister cells that contribute to the recalcitrance of M. abscessus infections

  • The enzyme might represent a metabolic vulnerability that could be targeted to enhance antibiotic efficacy

Experimental approaches to investigate these aspects include conditional knockdown of tpiA followed by infection studies in cellular and animal models, metabolomic profiling during infection, and protein interaction studies to identify potential non-canonical functions.

How can metabolomic approaches be used to characterize tpiA function in M. abscessus?

Metabolomic approaches offer powerful tools for characterizing tpiA function in M. abscessus, providing insights into both enzymatic activity and broader metabolic consequences:

• Targeted metabolomics for direct substrate/product quantification:

  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can be used to directly quantify DHAP and G3P levels

  • Sample preparation must include rapid quenching (e.g., cold methanol quenching) to prevent metabolite interconversion

  • Isotopically labeled internal standards improve quantification accuracy

  • This approach can confirm the accumulation of TPI substrates in conditional knockdown strains, similar to observations in M. tuberculosis

• 13C-labeled substrate flux analysis:

  • Feeding M. abscessus with 13C-labeled glucose or glycerol followed by mass isotopomer distribution analysis

  • This approach can map carbon flow through central metabolism and identify metabolic rerouting in response to tpiA manipulation

  • Key parameters to measure include:

    • Fractional enrichment in glycolytic/gluconeogenic intermediates

    • Label distribution in amino acids derived from glycolytic intermediates

    • Incorporation into cell wall precursors

• Untargeted metabolomics for system-wide effects:

  • Global metabolite profiling using high-resolution mass spectrometry can identify unexpected metabolic adaptations

  • Multivariate statistical analysis (PCA, PLS-DA) of metabolomic data can reveal patterns of metabolic rewiring

  • Time-course experiments during tpiA depletion can distinguish primary from secondary metabolic effects

• In situ metabolite imaging:

  • Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry of infected tissues

  • These techniques can localize metabolic perturbations within infection microenvironments

The experimental implementation requires:

What methodological challenges exist when studying tpiA in M. abscessus infection models?

Studying tpiA in M. abscessus infection models presents several methodological challenges that require specialized approaches:

• Genetic manipulation limitations:

  • The essentiality of tpiA complicates genetic studies, necessitating conditional expression systems

  • M. abscessus has lower transformation efficiency compared to other mycobacteria, requiring optimized protocols

  • The natural antibiotic resistance profile of M. abscessus limits selectable marker options

  • Solution: Use tetracycline-inducible systems adapted specifically for M. abscessus as described in the literature , with careful titration of inducer concentrations

• Cell culture infection model considerations:

  • M. abscessus exhibits strain-dependent variations in intracellular survival and cytotoxicity

  • Distinguishing smooth (S) and rough (R) morphotypes is crucial as they display different pathogenic properties

  • The robust growth rate of M. abscessus compared to M. tuberculosis requires adjusted infection protocols

  • Solution: Select appropriate cell lines (human bronchial epithelial cells for pulmonary models, macrophages for immune response), optimize MOI, and employ fluorescent reporters for real-time monitoring

• Animal model limitations:

  • Standard mouse models often fail to recapitulate key aspects of human M. abscessus infections

  • The zebrafish embryo model offers advantages for visualizing infection progression but has physiological differences from mammals

  • Solution: Consider specialized models such as cystic fibrosis transmembrane conductance regulator (CFTR)-deficient mice that better mimic human susceptibility

• Metabolic assessment challenges:

  • Intracellular bacteria are difficult to access for direct metabolic measurements

  • The host cell background complicates metabolomic analyses

  • Solution: Employ 13C-labeled substrates combined with LC-MS/MS for metabolic flux analysis, develop fluorescent biosensors for key metabolites, and use transcriptomics to infer metabolic states

• Technical considerations for in vivo assessment:

  • Standard colony-forming unit (CFU) determination is complicated by clumping of mycobacteria

  • Non-culturable but viable bacteria may be missed by traditional viability assays

  • Solution: Implement single-cell techniques such as fluorescence dilution assays to track bacterial replication, RNA-based viability assessments, and advanced imaging to visualize metabolic activity in situ

What future research directions should be prioritized for M. abscessus tpiA?

Several promising research directions emerge for advancing our understanding of M. abscessus tpiA:

• Drug discovery targeting unique features of M. abscessus tpiA:

  • Structure-based design of selective inhibitors exploiting structural differences from human TPI

  • High-throughput screening campaigns using recombinant enzyme to identify novel inhibitor scaffolds

  • Fragment-based approaches to develop allosteric inhibitors targeting non-conserved regions

  • Combination studies with existing antibiotics to identify synergistic interactions, particularly with β-lactams where synergy has been observed with other targets

• Systems biology integration:

  • Multi-omics approaches combining metabolomics, proteomics, and transcriptomics to develop comprehensive models of tpiA's role in M. abscessus metabolism

  • In silico genome-scale metabolic modeling to predict synthetic lethal interactions with tpiA

  • Network analysis to identify condition-specific essentiality and potential combination therapy targets

• Host-pathogen interaction studies:

  • Investigation of how tpiA activity influences M. abscessus survival in different host cell types relevant to disease

  • Examination of metabolic adaptation during chronic infection versus acute disease

  • Analysis of tpiA expression patterns in clinical isolates with varying virulence profiles

• Technological innovations:

  • Development of advanced genetic tools specifically adapted for M. abscessus, similar to those already developed for M. tuberculosis

  • Implementation of CRISPRi technologies for precise temporal control of gene expression

  • Application of single-cell techniques to understand heterogeneity in tpiA expression and function during infection